American Society of Hematology

In the upcoming Aplastic Anemia Clinical Case Webinar, explore the morphological and immunophenotypic nuances of bone marrow failure with a focus on aplastic anemia and the key considerations for differential diagnosis.

Sign up now: https://ow.ly/4Ha550YqgYL

#HemeSky #MedSky #Anemia

Nominations for ASH Scientific Committees are open!

As a member of a committee, you have the opportunity to:

🔬 Shape sessions

💡 Influence priorities

🤝 Foster collaboration

Nominate today! 🔗 https://ow.ly/pKYs50YqgPS

#HemeSky #MedSky

Sustained NIH funding is essential for the U.S. to maintain its global leadership in medical research and innovation. ASH is grateful for Congress keeping pace with rising research costs, ensuring we stay ahead in scientific discovery. https://ow.ly/GoBQ50YpjPt

#Fight4Hematology

In partnership with the Mayo Clinic Shared Decision Making National Resource Center, ASH has created a new shared decision-making tool to help clinicians and patients with AML understand options and plan for post-remission treatment together.

🔗 https://ow.ly/qjBW50YnfWM

Last chance to apply for the ASH Award for Research Careers in Hematology (ARCH). The successor to the ASH Bridge Grant, ARCH provides $150k to support research that advances the care of patients with blood disorders. Apply now: ow.ly/ivcj50Ym0Y3

#Fight4Hematology

What does it take to run a clinical trial?

The new ASH Clinical Trial Map walks you through every step of the process, from the first spark of an idea to full implementation and ongoing management.

Explore now: https://ow.ly/GeMT50Yoe2z

#HemeSky #ClinicalTrials #MedSky

Telomere biology disorders are multisystem, cancer-predisposing genetic conditions increasingly recognized in adults, often after years of missed diagnosis, and transplant remains the only therapy that alters their course.

Read now: ashpublications.org/...

#HemeSky #MedSky

On #RareDiseaseDay, your support can turn research into answers, treatments, and hope for people living with rare blood disorders.

Donate to the ASH Research Awards Fund: https://ow.ly/6yKo50Yng19
#Hematology

From AI-based image interpretation to machine learning prognosis models and single-cell analysis, artificial intelligence is shaping the future of hematology. Learn more in The Hematologist: ashpublications.org/...

#HemeSky #MedSky

Another successful ASH Hill Day is on the books! Members delivered a strong message on the need to support hematology research and care nationwide in FY 2027 and beyond. Visit ASH’s Advocacy Hub to learn how you can take action and be part of the #Fight4Hematology. www.hematology.org/advocacy/fig...

ASH has joined more than 230 organizations in supporting the American Academy of Pediatrics’ 2026 Recommended Child and Adolescent Immunization Schedule. Vaccines protect children, families, and communities from preventable diseases.
🔗 www.hematology.org/a...

#Fight4Hematology #HemeSky #MedSky

Happening tomorrow! 🚨 Discover how AI is transforming clinical transfusion and how high-throughput genomic blood typing is reshaping blood allocation. Join this Precision Hematology webinar to explore machine-learning approaches to improving transfusion outcomes.
Enroll now: academy.hematology.o...

TRUE or FALSE: Can hormonal birth control cause blood clots?

TRUE ✅ but the risk is low and returns to normal after stopping the pill. Talk to your doctor about the best birth control option for you.

Learn more: www.hematology.org/e...

#Hematology

What does strong clinical trial design look like in practice? The new ASH Toolkit for Clinical Trial Sponsors offers interactive, hematology-specific guidance for investigators and trial teams, helping translate best practices into real protocol decisions.

Check it out: clinicaltrials.hemat...

While adult AML treatment options continue to expand, access to novel therapies for children is frustratingly slow. A new article in The Hematologist examines the clinical trial and regulatory barriers shaping pediatric AML drug development. ashpublications.org/...

#HemeSky#MedSky

On Tuesday, join the ASH Journal Club for insights on applying #AI to allogeneic transplantation donor selection.

Save your spot: ow.ly/OJLg50YhOAB{

#MedSky #HemeSky #ASHTrainee

#AI in clinical transfusion meets high-throughput genomic blood typing in this Precision Hematology webinar. Learn how antigen profiling and machine learning are improving blood allocation and transfusion outcomes.

Enroll: academy.hematology.o...

#HemeSky #MedSky

Dr. Negrin shares in The Hematologist his outlook for the year ahead as ASH President, highlighting progress in hematology while emphasizing community, advocacy, and mentorship. Read the full article now: ashpublications.org/...
#HemeSky #MedSky

Can extreme endurance running change how red blood cells function? 🏃‍♀️🩸

New research published in Blood Red Cells & Iron suggests that ultra endurance races may damage red blood cells and reduce their flexibility.

Learn more in the press release: https://bit.ly/4ao3F59

#Hematology

Coming soon! ASH is collaborating with the @US_FDA for an exclusive workshop on regulatory science in #hematology.

Applications will open on March 10, 2026. Stay tuned!

Who are the Black pioneers in hematology whose contributions inspire you? Share their names and stories in the comments.

This #BlackHistoryMonth, ASH honors the Black pioneers in #hematology whose discoveries, leadership, and advocacy have shaped the field and continue to save lives. Their impact lives on in every breakthrough and every patient served.

ASH has published new guidelines for management of relapsed or refractory ALL in adolescents and young adults, supporting immunotherapy over traditional chemotherapy and individualized transplant decisions. Learn more: https://bit.ly/4aPFtb5

#Hematology #HemeOnc

ASH has released new guidelines for frontline management of ALL in adolescents and young adults. The recommendations focus on pediatric-inspired regimens, asparaginase use, and transplant decisions in first remission. Learn more: https://bit.ly/4aPFtb5

#Hematology #HemeOnc

Roses are red, platelets are too,
Hematology keeps thriving with every breakthrough. 🩸💌

This Valentine’s Day, show some love by supporting hematology research through the ASH Foundation: ow.ly/9v8r50YcZaK

#ValentinesDay #Hematology #Donate #Fight4Hematology

ASH is proud to announce the new ASH Award for Research Careers in Hematology (ARCH), successor to the ASH Bridge Grant. ARCH provides 150,000 dollars to support research that advances the care of patients with blood disorders. Apply: www.hematology.org/awards/caree...

#Fight4Hematology

ASH y el grupo LARAA están organizando un seminario web en vivo sobre anemia aplásica para hematólogos en América Latina, con enfoques prácticos basados en evidencia y consideraciones clínicas claves para la región.

📅 12 de febrero
🔗 Regístrate: https://ow.ly/ZGP350Y7Frx

#HemeSky #MedSky

Nominations are open for 2027 ASH committee and leadership positions! Step forward or recommend a colleague to help shape #hematology initiatives, support research, and bring new perspectives to the Society.


🔗 Submit your nomination now: https://ow.ly/WOYa50Y7Fci

#HemeSky #MedSky

ASH’s International Outreach Initiative (IOI) helps strengthen hematology care, research, and training in low- and middle-income countries by distributing free, high-quality educational resources. Apply now to get access:https://ow.ly/KcsL50Y63jG
#HemeSky #MedSky

Dr. Pavan spent decades studying rare diseases at NIH. Today, he’s battling one: first diagnosed with MDS-RARSt and, later, myelofibrosis. A stem cell transplant from his son saved his life, made possible in part by NIH-funded research. Learn more: https://ow.ly/XaWp50XXqtu

#Fight4Hematology